Pharmacology News

Rural counties in the United States had lower odds of reaching maximum potential buprenorphine treatment capacity, according to findings published in Drug and Alcohol Dependence.

Buprenorphine, a life-saving medication for opioid use disorder, is underutilized by physicians, according to researchers. 

An intervention significantly decreased the rate of potentially inappropriate prescribing among older adults in an ED setting, according to findings from a recent study.

SAN DIEGO — Medication-assisted treatment for opioid overdose remains largely inaccessible for pregnant women, according to research presented at the ACOG Annual Clinical and Scientific Meeting.

Zetia and proprotein convertase subtilisin/kexin type 9 inhibitors may reduce nonfatal myocardial infarction and stroke in adults with high or very high cardiovascular risk, according to findings published in The BMJ.

The FDA has approved a new indication for Olumiant as a treatment for adults hospitalized with COVID-19 who require supplemental oxygen, noninvasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

The FDA has issued a draft guidance for sponsors developing drugs as adjunctive treatment to a gluten-free diet in adults with celiac disease.

SAN DIEGO — Several abstracts were presented at the ACOG Annual Clinical & Scientific Meeting on the efficacy and safety of linzagolix, an investigational oral GnRH antagonist being developed for the treatment of fibroid-related symptoms.

Despite a slight decline in opioid prescription filling from 2016 to 2020, one-third of patients who had an electronic cardiac device implanted were given doses tied to increased risk for persistent use, researchers reported.

CHICAGO — About 70% of antibiotics are used in the outpatient setting, often without proper indications, according to a speaker at the ACP Internal Medicine Meeting.